Further more, Hsu [25] demonstrated the inhibition of the invasiveness of breast cancer cells by TET1 in vivo and that down-regulation of TET1 expression in patients with breast cancer correlates with poor survival. The gene discussed is TET1; the disease is breast carcinoma.